To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

Infosys Q3 net rises 6% at Rs 983cr

Bangalore: Infosys Technologies has announced its third quarter results. The company reported net profit at Rs 983 crore (Rs 9.83 billion) in the third quarter, up 5.81% versus Rs 929 crore (Rs 9.29 billion) in the previous quarter.

The company's revenues were up 5.91% at Rs 3655 crore (Rs 36.55 billion) versus Rs 3451 crore (Rs 34.51 billion) QoQ.

The group has posted a net profit after tax, exceptional item and minority interest of Rs 983 crore (Rs 9.83 billion) for the quarter ended December 31, 2006 as compared to Rs 649 crore (Rs 6.49 billion) for the quarter ended December 31, 2005. Total Income has increased from Rs 2527 crore (Rs 25.27 billion) for the quarter ended December 31, 2005 to Rs 3714 crore (Rs 37.14 billion) for the quarter ended December 31, 2006.

Agencies

Biotechnology major Biocon forays into nephrology space

Bangalore, Mar 09:  Biotechnology major Biocon on Thursday forayed into the nephrology space with the launch of a portfolio of five renal therapy products for the domestic and global markets, which it said was cheaper compared to MNC drug prices. The new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category, the company's Marketing Head Rakesh Bamzai said.The Bangalore-headquartered company's Chairman and Managing Director, Kiran Mazumdar-Shaw said.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login